{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:29:54Z","timestamp":1793017794703,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdcjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.jdiacomp.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T08:17:46Z","timestamp":1492503466000},"page":"1132-1138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Serum RBP4 and CKD: Association with insulin resistance and lipids"],"prefix":"10.1016","volume":"31","author":[{"given":"Maria Alice M.","family":"Domingos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Andrade","family":"Lotufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Judith","family":"Bense\u00f1or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Maria de Oliveira","family":"Titan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj3180001","article-title":"The lipocalin protein family: Structure and function","volume":"318","author":"Flower","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0010","first-page":"63","article-title":"Vitamin a metabolism: An update","volume":"3","author":"D'Ambrosio","year":"2011","journal-title":"Forum Nutr"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0015","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1172\/JCI105889","article-title":"Retinol-binding protein: The transport protein for vitamin a in human plasma","volume":"47","author":"Kanai","year":"1968","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0020","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0025","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0030","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.2337\/dc06-0360","article-title":"Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes","volume":"29","author":"Cho","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cmet.2007.06.002","article-title":"Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass","volume":"6","author":"Kl\u00f6ting","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10753-010-9219-y","article-title":"Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults","volume":"34","author":"Hermsdorff","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0045","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1210\/jc.2006-2668","article-title":"Plasma levels and adipose tissue messenger ribonucleic acid expression of retinol-binding protein 4 are reduced during calorie restriction in obese subjects but are not related to diet-induced changes in insulin sensitivity","volume":"92","author":"Vitkova","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0050","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1210\/jc.2006-1839","article-title":"Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects","volume":"92","author":"Haider","year":"2007","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0055","doi-asserted-by":"crossref","first-page":"E758","DOI":"10.1152\/ajpendo.90737.2008","article-title":"Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans","volume":"296","author":"Chavez","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0060","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1210\/jc.2006-2522","article-title":"Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor","volume":"92","author":"Promintzer","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/13813451003631421","article-title":"Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients","volume":"116","author":"Ulgen","year":"2010","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0070","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1007\/s00125-007-0743-8","article-title":"Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease","volume":"50","author":"Von Eynatten","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0075","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00125-006-0557-0","article-title":"Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP44) in insulin-resistant human subjects","volume":"50","author":"Graham","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0080","doi-asserted-by":"crossref","first-page":"E785","DOI":"10.1152\/ajpendo.00521.2007","article-title":"Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob\/ob mice","volume":"294","author":"Mody","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0009-8981(88)90293-8","article-title":"Effect of renal insufficiency on concentration of free retinol-binding protein in urine and serum","volume":"171","author":"Bernard","year":"1988","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0090","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/clinchem\/36.4.674","article-title":"Use of free and transthyretin bound retinol binding protein in serum as tests of vitamin a status in human: Effect of high creatinine concentrations in serum","volume":"36","author":"Burri","year":"1990","journal-title":"Clin Chem"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bbrc.2010.01.082","article-title":"Alterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters","volume":"393","author":"Henze","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0100","doi-asserted-by":"crossref","DOI":"10.1590\/1516-3180.2016.0272261116","article-title":"Chronic kidney disease - determinants of progression and cardiovascular risk. The PROGREDIR cohort study: Design and methods. Sao Paulo Med J (accepted)","author":"Domingos","year":"2017","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0105","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0110","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1590\/1516-3180.2014.9150812","article-title":"Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian longitudinal study of adult Health (ELSA-Brasil)","volume":"133","author":"Goulart","year":"2015","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/clinchem\/39.3.472","article-title":"Monoclonal antibody-based immunoenzymometric assays of retinol-binding protein","volume":"39","author":"Pereira","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0125","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1530\/eje.0.1340576","article-title":"Analysis of normal and truncated holo-and apo-retinol-binding protein (RBP4) in human serum: Altered ratios in chronic renal failure","volume":"134","author":"Jaconi","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-511X-7-29","article-title":"Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver","volume":"7","author":"Frey","year":"2008","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0135","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.2337\/db08-0866","article-title":"Evidence that kidney function but not type 2 diabetes determines retinol-binding protein 4 serum levels","volume":"57","author":"Henze","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0140","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: A systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0145","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/ndt\/gft435","article-title":"Insulin resistance in chronic kidney disease: New lessons from experimental models","volume":"29","author":"Koppe","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0150","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1681\/ASN.2015070756","article-title":"Impaired glucose and insulin homeostasis in moderate-severe CKD","volume":"27","author":"de Boer","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0272-6386(89)80201-X","article-title":"Insulin resistance of uremia","volume":"14","author":"Hager","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0160","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.jrn.2007.10.015","article-title":"Inflammation and insulin resistance in uremia","volume":"18","author":"Zanetti","year":"2008","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0170","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2215\/CJN.05230513","article-title":"Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4","volume":"9","author":"Xu","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0175","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1046\/j.1523-1755.1998.00898.x","article-title":"Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease","volume":"53","author":"Fliser","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0180","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/ajcn\/86.5.1642","article-title":"Body mass index and fat mass are the primary correlates of insulin resistance in non-diabetic stage 3-4 chronic kidney disease patients","volume":"86","author":"Trirogoff","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2265.2007.03072.x","article-title":"Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease","volume":"68","author":"Seo","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0190","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.1210\/jc.2016-1320","article-title":"Retinol-binding protein 4 induces hepatic mitochondrial dysfunction and promotes hepatic steatosis","volume":"101","author":"Liu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2017.04.013_bb0195","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: Novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717301253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872717301253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T17:43:33Z","timestamp":1601919813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872717301253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S1056872717301253"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.013","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum RBP4 and CKD: Association with insulin resistance and lipids","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}